CYGB and metabolic dysfunction-associated steatohepatitis: Furthermore, Cygb−/− mice exhibited increases in liver inflammation, fibrosis and cancer development in a non-alcoholic steatohepatitis (NASH) model induced by a choline-deficient L-amino acid-defined diet via activation of the oxidative stress pathway20.